Accelerate Infectious Disease Prior Authorization Automation

Klivira delivers robust infectious disease prior authorization automation, specifically designed to streamline approvals for critical, high-cost therapies like antivirals, antifungals, and OPAT regimens.

Infectious disease care often hinges on timely access to specialized, high-cost medications and complex treatment plans, making efficient prior authorization critical. Delays in PA can directly impact patient outcomes and revenue cycles, particularly for time-sensitive conditions and extended therapies. Klivira addresses these challenges by automating the intricate PA process, improving throughput and reducing administrative burden.

The Unique Challenges of Infectious Disease Prior Authorization

Infectious disease prior authorization involves a distinct set of complexities, driven by the high cost and strict medical necessity criteria for many antimicrobial, antiviral, and antifungal agents. Regimens for conditions like HIV, HCV, and OPAT often require extensive documentation and frequent re-authorizations, posing significant administrative strain on ID clinics and health systems.

High-Volume PA Categories in Infectious Disease

Klivira's platform is engineered to manage the specific prior authorization demands prevalent in infectious disease practices. Our automation capabilities are particularly effective for high-volume categories, including complex antiviral regimens for HCV and HIV, critical antifungal therapies, and the intricate requirements of Outpatient Parenteral Antibiotic Therapy (OPAT).

Key Areas Where Klivira Optimizes ID Prior Authorization

Antivirals (HCV, HIV): Automated submission and tracking for high-cost, multi-drug regimens, reducing manual data entry and improving approval speed.
Antifungals: Streamlined processing for specialized antifungal agents, often requiring specific diagnostic criteria and treatment plans.
OPAT: Efficient management of initial and recurring authorizations for extended outpatient IV antibiotic therapies, a critical component of ID care.
Antimicrobial Stewardship Support: Facilitating timely PA for appropriate antibiotic use, aligning with stewardship goals without creating access barriers.
Complex Regimen Support: Handling multi-drug therapies and step-therapy protocols common in ID with integrated logic and documentation prompts.

Seamless Integration for Enhanced Workflow

Klivira integrates directly with your existing EMR systems via SMART on FHIR, ensuring patient data, clinical notes, and treatment plans flow seamlessly into the prior authorization request. This eliminates redundant data entry, reduces transcription errors, and provides a comprehensive view of the patient's record to support medical necessity documentation.

Payer Portal Automation and X12 278 Efficiency

Our platform automates interactions with payer portals, leveraging RPA for efficient submission and status checks. For payers supporting electronic prior authorization, Klivira utilizes the X12 278 transaction set and supports Da Vinci PAS implementation, enabling faster, more standardized communication and reducing manual follow-ups.

Frequently asked questions

How does Klivira handle the unique documentation required for OPAT prior authorizations?

Klivira's system can be configured to prompt for and integrate specific documentation elements critical for OPAT, such as infection type, antibiotic choice, duration of therapy, and home health agency details. Our automation streamlines the submission of these comprehensive packets to payers, reducing delays.

Can Klivira help with prior authorizations for new or experimental infectious disease therapies?

While new therapies often require more manual review due to evolving payer policies, Klivira centralizes the submission process. Our platform ensures all available clinical data is presented comprehensively, and our tracking tools provide real-time status updates, allowing your team to focus on appeals or peer-to-peer discussions if necessary.

Is Klivira compliant with HIPAA regulations when handling PHI for infectious disease patients?

Yes, Klivira is built with robust security measures and strict adherence to HIPAA guidelines to protect ePHI. Our platform employs encryption, access controls, and audit trails to ensure the confidentiality, integrity, and availability of patient data throughout the prior authorization process.

How does Klivira support antimicrobial stewardship programs through PA automation?

By accelerating the PA process for appropriate, guideline-driven antimicrobial therapies, Klivira helps ensure patients receive the right treatment promptly. This reduces the administrative burden on ID specialists, allowing them to focus on clinical decision-making that aligns with stewardship goals, rather than manual PA tasks.

Does Klivira integrate with specific EMRs commonly used in ID clinics?

Klivira offers robust integration capabilities with leading EMR systems via SMART on FHIR, ensuring compatibility with a wide range of clinical environments. This allows for seamless data exchange of patient demographics, diagnoses, lab results, and treatment plans directly into the prior authorization workflow.